Bioceramics are a subclass of ceramic materials. These materials are used to repair and replace damaged tissues and structures in the body. They are typically made of resorbable calcium phosphates, hydroxyapatite, and bioactive glass. Bioceramics have a range of advantages, including good resorption rate, a high Young modulus, and the ability to form a chemical bond with bone. Some common materials used in bioceramics are calcium phosphates. They include tricalcium phosphate b (b TCP) and hydroxyapatite. Both crystalline materials have a certain amount of resorptive property, which can be controlled through grain size. Apatite is a key component in direct bonding with bone. Irradiation of hydroxyapatites can alter their structure, thereby limiting their biological activity.
Market Statistics:
The global Bioceramics Market is estimated to account for US$ 4399.4 Mn in terms of value by the end of 2023.
Global Bioceramics Market: Drivers
Growing geriatric population is increasing incidences of spinal cord and ortho-biological surgeries. This is driving demand for medical implants such as knee, hip, wrist, shoulder, elbow, etc. thus propelling bioceramics market growth. According to data from World Population Prospects: the 2019 Revision, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over.
Global Bioceramics Market: Opportunities
Increasing application of biocermics for replacing diseased hard tissues of the body is expected to provide significant growth opportunities. Bio ceramics offers better response than metals or polymers in tissues. They have ability to bond with the bone. For past 50 years, a lot of R &D on Bio ceramics, such as alumina, zirconia, tricalcium phosphate, hydroxyapatite and bioactive glasses have developed modern medical industry.
Global Bioceramics Market: Restraints
However, the materials have limitations and are often not as durable as conventional ceramics. Furthermore, the implant must be able to withstand constant motion. So these factors are expected to hinder market growth.
Global Bioceramics Market - Impact of Coronavirus (Covid-19) Pandemic:
The outbreak of Covid-19 pandemic has negatively impacted growth of the bioceramics market due to gap production, supply, and demand. This is due to travel restriction in order to curb the spread of infection.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/bioceramics-market-5529
Key Takeaways:
The global Bioceramics market was valued at US$ 4,187.2 Mn in 2022 and is forecast to reach a value of US$ 5885 Mn by 2030 at a CAGR of 4.35% between 2023 and 2030.
Aluminium Oxide segment held dominant position in the global Bioceramics market in 2022, accounting for 49% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.
Global Bioceramics Market Trends:
Increasing health concerns and the growing popularity of minimally invasive procedures are other factors projected to increase the market size. Moreover, the increasing availability of advanced medical care facilities in this region is also projected to boost the market growth.
Increasing demand from dentistry is a recent trend in biocermics market. Bioceramics are increasingly being used in dentistry. This includes a variety of applications, such as filling bone defects, pulp capping, and sinus obliteration. Although these materials are durable, they are not ideal for replacement of damaged bone. As such, they are aesthetically pleasing and contain components that are safe for the human body. Additionally, they must be able to be detected on radiographs.
Global Bioceramics Market: Competitive Landscape
CoorsTek, Inc., Kyocera Corporation, Morgan Advanced Materials, CeramTec, BONESUPPORT, COLLAGEN MATRIX, BERKELEY ADVANCED BIOMATERIALS INC., and CERAMTEC
Global Bioceramics Market: Recent Developments
In January 2017, Amedica announces proposed public offering of common stock and warrants
In January 2017, Amedica announces successful completion of first taurus(TM) pedicle screw system surgery
In May 2022, Septodont, a manufacturer of dental anesthetics, announces a new and exciting bioceramic root canal sealer – BioRoot™ Flow. It creates an alkaline environment unfavorable for bacterial growth. It can be used with warm and cold obturation techniques. Moreover, it is easy and fast to removal when retreating
In August 2020, Arcamed has converted 6,000 square feet of office space into manufacturing space, supporting expanded instrument and implant manufacturing capabilities and capacity to meet growing customer demand beyond its core business of cases and trays.
